HDAC Inhibitor-Induced Mitotic Arrest Is Mediated by Eg5/KIF11 Acetylation
- 1 April 2017
- journal article
- Published by Elsevier in Cell Chemical Biology
- Vol. 24 (4) , 481-492.e5
Abstract
No abstract availableKeywords
Funding Information
- NIH (GM121061, P30 ES020957, P30 CA022453, S10 OD010700, P30CA22453)
- Wayne State University
This publication has 56 references indexed in Scilit:
- Acetylation site specificities of lysine deacetylase inhibitors in human cellsNature Biotechnology, 2015
- Inhibition of Histone Deacetylase 3 Produces Mitotic Defects Independent of Alterations in Histone H3 Lysine 9 Acetylation and MethylationMolecular Pharmacology, 2010
- Protein Acetylation and Histone Deacetylase Expression Associated with Malignant Breast Cancer ProgressionClinical Cancer Research, 2009
- Expression of Hypoxia-Inducible Factor-1α, Histone Deacetylase 1, and Metastasis-Associated Protein 1 in Pancreatic CarcinomaPancreas, 2008
- Class I Histone Deacetylase Expression Has Independent Prognostic Impact in Human Colorectal Cancer: Specific Role of Class I Histone Deacetylases In vitro and In vivoClinical Cancer Research, 2008
- SK-7041, a new histone deacetylase inhibitor, induces G2-M cell cycle arrest and apoptosis in pancreatic cancer cell linesCancer Letters, 2006
- The NucleosomeCell, 2004
- Histone deacetylase inhibitor selectively induces p21 WAF1 expression and gene-associated histone acetylationProceedings of the National Academy of Sciences, 2000
- Identification of p130 as an in VivoSubstrate of Receptor Protein-tyrosine Phosphatase αJournal of Biological Chemistry, 2000
- A role for histone deacetylase activity in HDAC1-mediated transcriptional repressionProceedings of the National Academy of Sciences, 1998